Invasive breast cancer following ductal and lobular carcinoma in situ of the breast

International Journal of Cancer

Volumn 116, Issue 5, 2005, Pages 820-823

  Levi, Fabio ^a   Randimbison, Lalao ^a   Te, Van Cong ^a   La Vecchia, Carlo ^a,b,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast neoplasms; Cancer registry; Ductal carcinoma in situ; Lobular carcinoma in situ; Noninvasive breast neoplasms; Second primary

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CARCINOMA IN SITU; FEMALE; HUMAN; INVASIVE CARCINOMA; LIFE TABLE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SWITZERLAND;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; RISK;

EID: 23244449232     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20870     Document Type: Article

References (31)

1. Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med 2004;350:1430-41.
2. Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 2004;96:906-20.
3. Bulliard JL, De Landtsheer JP, Levi F. Results from the Swiss mammography screening pilot programme. Eur J Cancer 2003;39:1761-9.
4. Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 2003;289:1421-4.
5. Levi F, Te VC, Randimbison L, La Vecchia C. Increase in lobular breast cancer incidence in Switzerland. I Int J Cancer 2003;107:164-5.
6. Verkooijen HM, Fioretta G, Vlastos G, Morabia A, Schubert H, Sappino AP, Pelte MF, Schäfer P, Kurtz J, Bouchardy C. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int J Cancer 2003;104:778-81.
7. Levi F, Te VC, Randimbison L, La Vecchia C. Trends of in situ carcinoma of the breast in Vaud, Switzerland. Eur J Cancer 1997;33:903-6.
8. Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, Wolmark N, Wickerham DL, Deutsch M, Ore L. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-6.
9. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolkman N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 2001;28:400-18.
10. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathological findings from the National Surgical Adjuvant Breast Project (NSAB) Protocol B-17: intraductal carcinoma (ductal carcinoma in situ). Cancer 1995;75:1310-9.
11. Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N. Pathological findings from the National Surgical Adjuvant Breast Project (NSAB) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999;86:429-38.
12. Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, Avril A, Sylvester R, Mignolet F, Bartelink H, Van Dongen JA. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial 10853. Lancet 2000;355:528-33.
13. Bijker N, Petersen JL, Duchateau L, Julien JP, Fentiman IS, Duval C, Di Palma S, Simony-Lafontaine J, de Mascarel I, van de Vijver MJ. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263-71.
14. Houghton J, George WD, Cuzick J, Dugan C, Fentiman IS, Spittle M. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 2003;362:95-102.
15. Wämberg F, Yuen J, Holmberg L. Risk of subsequent invasive breast cancer after breast carcinoma in situ. Lancet 2000;355:724-5.
16. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995;76:1197-200.
17. Habel LA, Moo RE, Daling JR, Holte S, Rossing MA, Weiss NS. Risk of contralateral breast cancer among women with carcinoma in situ of the breast. Ann Surg 1997;225:69-75.
18. Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based Surveillance, Epidemiology and End Results Program. Arch Intern Med 2000;160:953-8.
19. Claus EB, Stowe M, Carter D, Holford T. The risk of contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry. Breast 2003;12:451-6.
20. Franceschi S, Levi F, La Vecchia C, Randimbison L, Te VC. Second cancers following in situ carcinoma of the breast. Int J Cancer 1998;77:392-5.
21. Levi F, Te VC, Randimbison L. Statistics from the Registry of the Canton of Vaud, Switzerland, 1993-1996. In: Parkin DM, Whelan S, Ferlay J, Teppo L, Thomas DB, eds. Cancer incidence in five continents, vol. VIII, IARC Scientific Publication No 155. Lyon: International Agency for Research on Cancer, 2002. 460-1.
22. World Health Organization. International classification of diseases for oncology, ICD-O. Geneva: World Health Organization, 1976. 131.
23. Baxter NN, Vimig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004;96:443-8.
24. Morrow M. The certainties and the uncertainties of ductal carcinoma in situ. J Natl Cancer Inst 2004;96:424-5.
25. Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985;68:99-112.
26. Vaittinen P, Hemminki K. Risk factors and age-incidence relationship for contralateral breast cancer. Int J Cancer 2000;88:998-1002.
27. Levi F, Randimbison L, Te VC, La Vecchia C. Contralateral breast cancer in Vaud, Switzerland. Int J Cancer 2003;93:612-3.
28. Peto J, Mack TM. High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 2000;26:411-4.
29. Easton D. Breast cancer-not just whether but when? Nat Genet 2000;26:390-1.
30. Peto R. Only one breast remains at risk of contralateral cancer [Letter]. Br J Cancer 1987;55:352.
31. Levi F, Randimbison L, Te VC, La Vecchia C. Second primary cancers in breast cancer patients in Vaud, Switzerland. Cancer Causes Control 1998;9:463-5.